期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Synthesis and antitumor activity of 7-azaindirubin 被引量：2

Synthesis and antitumor activity of 7-azaindirubin
下载PDF
导出
摘要 Twenty 7-azaindirubin derivatives were designed and synthesized. Their antitumor activities were evaluated in vitro against DU145 cell line. The pharmacological results showed that most of the prepared compounds displayed the excellent activity. Compound 18 exhibited the most potent antitumor activity among the tested compounds. Twenty 7-azaindirubin derivatives were designed and synthesized. Their antitumor activities were evaluated in vitro against DU145 cell line. The pharmacological results showed that most of the prepared compounds displayed the excellent activity. Compound 18 exhibited the most potent antitumor activity among the tested compounds.
作者 Zhao Hui Wang Wen Yun Li FU Long Li Lei Zhang Wei Yi Hua Jing Cai Cheng Qi Zheng Yao
机构地区 Department of Organic Chemistry Nanjing School of Pharmacy Nanjing Wuxi JC Pharmaceutical Technology Inc.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第5期542-544,共3页 中国化学快报（英文版）
关键词 7-Azaindirubin SYNTHESIS Antitumor activity 7-Azaindirubin Synthesis Antitumor activity
分类号 TQ463.5 [化学工程—制药化工] TQ457.2 [化学工程—农药化工]
  • 相关文献

参考文献17

  • 1X.J. Ji, ER. Zhang, J.L. Lei, Acta Pharrn. Sin. 16 (1981) 146.
  • 2G.Y. Wu, ED. Fang' J.Z. Liu, et al. Chin. Med. J. 60 (1980) 451.
  • 3G.Y. Wu, J.Z. Liu,-F.D. Fang, et al. Sci. Sin. 25 (1982 107i).
  • 4L. Zhang, G.Y. Wu, C.C. Qiu, Acta Acad. Med. Sin. 7 (1985) 112.
  • 5R. Hoessel, S. Leclerc, L. Meijer, et al. Nat. Cell. Biol. 1 (1999) 60.
  • 6W.G. Dunphy, Methods Enzymol. 283 (1997) 1.
  • 7D. Morgan, Annu. Rev. Cell Dev. Biol. 13 (1997) 261.
  • 8P.K. Vogt, S.I. Read, Curr. Top. Microbiol. Immunol. 227 (1998) 1.
  • 9C. Li, Y. Go, Z. Mao, et al. Bull. Chem. Soc. Jpn. 69 (1996) 1621.
  • 10K. Hughes, B.J. Pulverer, E Theocharous, et al. J. Biochem. 203 (1992) 305.

同被引文献15

  • 1A.J.Verbiscar. Journal of Medicinal Chemistry . 1972
  • 2E.Desarbre,J.Y.Merour. Tetrahedron Letters . 1994
  • 3Institute of Haematology,Chinese Academy of Medical Science. Chin.J.Int.Med . 1979
  • 4L.M.Wu,Y.P.Yang,Z.H.Zhu. Commun.Chin.Herb.Med . 1976
  • 5Q.T.Zheng,D.J.Lu,S.L.Yang. Commun.Chin.Herb.Med . 1979
  • 6K.Hughes,B.J.Pulverer,P.Theocharous,et al. European Journal of Biochemistry . 1991
  • 7P.Polychronopoulos,P.Magiatis,A.L.Skaltsounis,et al. Journal of Medicinal Chemistry . 2004
  • 8Leclerc S,Gamier M,Hoessel R,et al.Indirubins inhibit glycogen synthase kinase-3 betaand CDK5/p25,two protein kinases involved in abnormal tau phosphorylation in Alzheimer‘sdisease:A property common to most cyclin-dependent kinase inhibitors. Journal of Biological Chemistry . 2001
  • 9Damiens E,Baratte B,Marie D,et al.Anti-mitotic properties of indirubin-3’-monoxime,a CDK/GSK-3inhibitor:induction of endoreplication following prophase arrest. Oncegene . 2001
  • 10BEAUCHARD A,FERANDIN Y,FRERE S,et al.Synthesis of novel5.substituted indirubins as proteinkinases inhibitors. Bioorganic and Medicinal Chemistry . 2006

引证文献2

二级引证文献10

Chinese Chemical Letters
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部